Brett B. Yarusi, MD1; Vikrant S. Jagadeesan, MD2; Arif Jivan, MD, PhD2;
Erin D. Unger, MD2; Lowie M.R. Van Assche, MD2; Tim S. Provias, MD, MPH2; James D. Flaherty, MD2; Keith H. Benzuly, MD2; Daniel R. Schimmel, MD, MS2
Brett B. Yarusi, MD1; Vikrant S. Jag...
We performed a retrospective review of patients who were excluded from preapproval trials of coronary IVL and underwent CAC modification with the off-label use of a peripheral IVL system.
We performed a retrospective review of patients who were excluded from preapproval trials of coronary IVL and underwent CAC modification with the off-label use of a peripheral IVL system.